Subsequent inhibition of this pathway reduced the stimulatory effects and the researchers concluded that there is biological significance of ACA11 in HCC, and that further research may provide therapeutic targets [79]. This evidence concerns the gene SCARNA22 and hepatocellular carcinoma.